ACCELERACE LIFE SCIENCE, BIOTECH & MEDTECH

Transcription

1 ACCELERACE LIFE SCIENCE, BIOTECH & MEDTECH

2 EUROPE S LEADING ACCELERATOR

3 WHAT WE DO SPOT WE ATTRACT AND SELECT THE BEST STARTUPS AND TALENTS IN THE WORLD TRAIN WE DEVELOP STARTUPS IN ORDER TO UNLEASH THEIR FULL POTENTIAL FUND WE HELP FINANCING THEIR ROUTE TO SUCCESS ENGAGE WE DEVELOP & FACILITATE EFFECTIVE STAKEHOLDER ENGAGEMENT

4 OUR TOOLS SPOT WE ATTRACT AND SELECT THE BEST STARTUPS AND TALENTS IN THE WORLD ACCELERATOR TRAIN INVEST WE DEVELOP STARTUPS IN ORDER TO UNLEASH THEIR FULL POTENTIAL MENTOR NETWORK OF EXCELLENCE WE FINANCE THEIR ROUTE TO SUCCESS ENGAGE FUNDS UNDER WE DEVELOP & FACILITATE MANAGEMENT EFFECTIVE STAKEHOLDER ENGAGEMENT Invest

5 STARTUPS 400+ ALUMNI 88% SURVIVAL RATE 70+ INVESTMENTS 66% RAISE CAPITAL YEARS (AND MUCH MORE )

6

7 ScaleUP accelerator The mission To turn more startup companies into scalable businesses and to boost entrepreneurial talent The means what you get 200+ hours of coaching A systematic approach lean way to success Individualised programme takes outset in the critical issues of the individual case Access to mentoring and learning labs Access to camps and workshops Access to capital and broad Accelerace network Work with corporate partners Founders pack No payment, no equity Open internationally Hypothesis Experiments Project plan Data Scientific hypothesis Validation /learning Business plan Validation /learning Assumption Testing

8 Corporate engagements Nordic Mentor Network for Entrepreneurship

9

10 Nordic Mentor Network for Entrepreneurship

11 The Nordic Mentor Network for Entrepreneurship Mission: To increase the success rate of life science startup companies in the Nordic countries Vision: To become a key element in the Nordic life science ecosystem that unlocks a great knowledge potential a beacon in the ecosystem

12 The Nordic issue - World class science but lack of efficient commercialisation Spin-out rate and success far higher in the US Critical mass and access to qualified labour Access to capital University industry collaboration Culture Access to knowledge- and social capital Denmark and Sweden are: No. 2 and 3 in terms of life science patents filed per capita No. 2 and 7 in terms of citation index for life sciences No. 5 and 4 most innovative countries Yet, the rate of spin-outs and their success is modest

13 NOME concept Based on principles from MIT s Venture Mentoring Service Unbiased and conflict free mentoring Volunteer Formalised rules of engagement Team mentoring High entry bar Trusted atmosphere Network owned by the mentors

14 NOME is Nordic and Transatlantic NOME World Map Nordic partners in Denmark Sweden Norway Finland US partner in North Carolina CommonWeal Ventures

15 5 REASONS TO TALK ACCESS TO STARTUPS Get access to the best deal flow of life science, biotech & medtech startups in the Nordic countries and the most comprehensive insight ECOSYSTEM INSIGHT & NETWORK Access to thought leadership in innovation, entrepreneurship and startups as well as to key organisations through a major player in the Nordic ecosystem CAPITAL Get funding for your development through our network of VC s and business angels, non-dilutive funding opportunities and investment from Accelerace PARTNERSHIPS Engage in pharma and large biotech/medtech partners in the Nordics to mediate your partnerships BRANDING & IMAGE Build your image and position in the Nordics

16 ACCELERACE ALUMNI EXAMPLES RESCUES FAILED ONCOLOGY DRUGS BY RUNNING SMALL PHASE II TRIALS IN SELECTED HIGH LIKELIHOOD RESPONDERS. SELECTION IS BASED ON PROPRIETARY DRUG RESPONSE PREDICTION (DRP ) TOOL DEVELOPMENT OF BIOLOGICAL MEMBRANES FOR WATER TREATMENT. FOR USE IN WOUND HEALING OF CHRONIC ULCERS BY TREATMENT WITH AUTOLOGOUS BLOOD.

17 ACCELERACE PARTNERS IN LIFE SCIENCES Merck Ventures

18 Our team Morten Heide Business Accelerator & Investor Experience: Fisher Bioimage ApS part of Thermo Fischer, Bioimage A/S, Novo Nordisk, Danmarks Jordbrugsforskning Peter Birk Business Accelerator & Investor Experience: EpiTherapeutics ApS, ACE BioSciences A/S, and Pharmexa A/S Jón Ingi Benediktsson Business Accelerator Experience: SEED Capital, OpenTeleHealth, Medichanical Engineering Aps and Curasight Will Wright Business Accelerator Experience: Evaxion Biotech, TychoBio, Veolia and Novozymes. Arvind Hundal Business Accelerator Experience: Ziarco Pharma, Zealand Pharma, 7TM Pharma and AstraZeneca Valentin Lubbe Program Manager NOME Experience: BioBusiness Innovation Program, ValuConsult and COBIS

19 LET S BUILD SOMETHING TOGETHER!